Small-scale systems for in vivo drug delivery.

Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine (2008) 4.59

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A (2008) 3.62

Wearable and implantable wireless sensor network solutions for healthcare monitoring. Sensors (Basel) (2011) 3.35

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev (2012) 3.34

Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol (2005) 2.56

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A (2010) 2.21

Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed (2007) 2.12

Drug release from electric-field-responsive nanoparticles. ACS Nano (2011) 1.84

Micro-scale devices for transdermal drug delivery. Int J Pharm (2008) 1.81

Nanoparticle hydrophobicity dictates immune response. J Am Chem Soc (2012) 1.57

An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors. Sci Transl Med (2015) 1.44

Enabling individualized therapy through nanotechnology. Pharmacol Res (2010) 1.28

Boron polylactide nanoparticles exhibiting fluorescence and phosphorescence in aqueous medium. ACS Nano (2008) 1.20

Laser jetting of femto-liter metal droplets for high resolution 3D printed structures. Sci Rep (2015) 1.19

Peptide-functionalized nanogels for targeted siRNA delivery. Bioconjug Chem (2009) 1.16

Multiresponse strategies to modulate burst degradation and release from nanoparticles. ACS Nano (2010) 1.14

Local drug delivery with a self-contained, programmable, microfluidic system. Biomed Microdevices (2009) 1.12

Correlations between structure, material properties and bioproperties in self-assembled beta-hairpin peptide hydrogels. Faraday Discuss (2008) 1.10

Painting blood vessels and atherosclerotic plaques with an adhesive drug depot. Proc Natl Acad Sci U S A (2012) 1.09

Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev (2016) 1.08

Electroactive controlled release thin films. Proc Natl Acad Sci U S A (2008) 1.08

Visualizing light-triggered release of molecules inside living cells. Nano Lett (2010) 1.07

Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brain. Int J Nanomedicine (2012) 1.05

Inkjet formation of unilamellar lipid vesicles for cell-like encapsulation. Lab Chip (2009) 1.05

Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials (2011) 1.04

Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy. Clin Cancer Res (2009) 1.04

Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev (2007) 1.03

Drug release from hydrazone-containing peptide amphiphiles. Chem Commun (Camb) (2011) 1.02

Flow chamber analysis of size effects in the adhesion of spherical particles. Int J Nanomedicine (2007) 0.99

Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. Lab Chip (2008) 0.99

The use of micro- and nanospheres as functional components for bone tissue regeneration. Tissue Eng Part B Rev (2011) 0.98

Microcapsules ejecting nanosized species into the environment. J Am Chem Soc (2008) 0.98

Reversible pH lability of cross-linked vault nanocapsules. Nano Lett (2008) 0.97

Chitosan nanoparticle-based neuronal membrane sealing and neuroprotection following acrolein-induced cell injury. J Biol Eng (2010) 0.96

Microfabricated microbial fuel cell arrays reveal electrochemically active microbes. PLoS One (2009) 0.95

The margination propensity of spherical particles for vascular targeting in the microcirculation. J Nanobiotechnology (2008) 0.95

A stimuli-responsive hydrogel for doxorubicin delivery. Biomaterials (2010) 0.94

Size-dependent control of colloid transport via solute gradients in dead-end channels. Proc Natl Acad Sci U S A (2015) 0.93

Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade. ACS Nano (2014) 0.93

Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus. J Control Release (2013) 0.93

Emerging microtechnologies for the development of oral drug delivery devices. Adv Drug Deliv Rev (2012) 0.92

Nanostructure-templated control of drug release from peptide amphiphile nanofiber gels. Soft Matter (2012) 0.91

Tunable growth factor delivery from injectable hydrogels for tissue engineering. J Am Chem Soc (2011) 0.91

Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo. ACS Nano (2015) 0.91

Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet (2011) 0.90

Electrically controlled drug delivery from graphene oxide nanocomposite films. ACS Nano (2014) 0.90

Challenges and breakthroughs in recent research on self-assembly. Sci Technol Adv Mater (2008) 0.90

Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery. Int J Nanomedicine (2006) 0.89

Microscale technologies and modular approaches for tissue engineering: moving toward the fabrication of complex functional structures. ACS Nano (2011) 0.89

Iron oxide nanoparticle-based magnetic resonance method to monitor release kinetics from polymeric particles with high resolution. Anal Chem (2012) 0.88

Optical Fibre Pressure Sensors in Medical Applications. Sensors (Basel) (2015) 0.88

Sustained Release of a Monoclonal Antibody from Electrochemically Prepared Mesoporous Silicon Oxide. Adv Funct Mater (2010) 0.88

Implantable Smart Technologies (IST): Defining the 'Sting' in Data and Device. Health Care Anal (2016) 0.87

Implantable, multifunctional, bioresorbable optics. Proc Natl Acad Sci U S A (2012) 0.86

Biosafety of non-surface modified carbon nanocapsules as a potential alternative to carbon nanotubes for drug delivery purposes. PLoS One (2012) 0.86

Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers. Sci Rep (2016) 0.86

Development of vertical SU-8 microneedles for transdermal drug delivery by double drawing lithography technology. Biomicrofluidics (2013) 0.85

Micro/nanofabricated platforms for oral drug delivery. J Control Release (2015) 0.85

Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus. PLoS One (2011) 0.85

Wearable and implantable pancreas substitutes. J Artif Organs (2012) 0.84

Just a Cog in the Machine? The Individual Responsibility of Researchers in Nanotechnology is a Duty to Collectivize. Sci Eng Ethics (2015) 0.84

Protein encapsulation in and release from monodisperse double-wall polymer microspheres. J Pharm Sci (2013) 0.84

Spatial charge configuration regulates nanoparticle transport and binding behavior in vivo. Angew Chem Int Ed Engl (2012) 0.84

A Two-Magnet System to Push Therapeutic Nanoparticles. AIP Conf Proc (2010) 0.83

Sponge-like nanostructured conducting polymers for electrically controlled drug release. Electrochem commun (2009) 0.83

Use of a nanoporous biodegradable miniature device to regulate cytokine release for cancer treatment. J Control Release (2011) 0.83

Optofluidic fabrication for 3D-shaped particles. Nat Commun (2015) 0.83

Chitosan nanoencapsulated exogenous trypsin biomimics zymogen-like enzyme in fish gastrointestinal tract. PLoS One (2013) 0.83

Thermoelectric materials by using two-dimensional materials with negative correlation between electrical and thermal conductivity. Nat Commun (2016) 0.82

Microfabrication technologies for oral drug delivery. Adv Drug Deliv Rev (2011) 0.82

An in vitro release study of 5-fluoro-uracil (5-FU) from swellable poly-(2-hydroxyethyl methacrylate) (PHEMA) nanoparticles. J Mater Sci Mater Med (2009) 0.82

Biodegradable xylitol-based elastomers: in vivo behavior and biocompatibility. J Biomed Mater Res A (2010) 0.82

One Polymorph and Various Morphologies of Phenytoin at a Silica Surface Due to Preparation Kinetics. Cryst Growth Des (2014) 0.81

Composite polylactic-methacrylic Acid copolymer nanoparticles for the delivery of methotrexate. J Drug Deliv (2012) 0.81

Click hybridization of immune cells and polyamidoamine dendrimers. Adv Healthc Mater (2014) 0.81

Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans. J Cell Mol Med (2012) 0.81

Biomimetic micro∕nanostructured functional surfaces for microfluidic and tissue engineering applications. Biomicrofluidics (2011) 0.81

Electrically Triggered Release of a Small Molecule Drug from a Polyelectrolyte Multilayer Coating. Chem Mater (2010) 0.81

Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity. Cancer Prev Res (Phila) (2014) 0.81

Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev (2015) 0.80

Characterization of drug-release kinetics in trabecular bone from titania nanotube implants. Int J Nanomedicine (2012) 0.79

Alternating Magnetic Field Controlled, Multifunctional Nano-Reservoirs: Intracellular Uptake and Improved Biocompatibility. Nanoscale Res Lett (2009) 0.79

Mimicking subsecond neurotransmitter dynamics with femtosecond laser stimulated nanosystems. Sci Rep (2014) 0.79

Recent advances on smart TiO2 nanotube platforms for sustainable drug delivery applications. Int J Nanomedicine (2016) 0.78

Heat localization for targeted tumor treatment with nanoscale near-infrared radiation absorbers. Phys Med Biol (2012) 0.78

Packaging biological cargoes in mesoporous materials: opportunities for drug delivery. Expert Opin Drug Deliv (2014) 0.78

Controlled release of growth factors on allograft bone in vitro. Clin Orthop Relat Res (2008) 0.77

Nanoparticle-facilitated functional and molecular imaging for the early detection of cancer. Front Mol Biosci (2014) 0.77

A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules. Arch Biochem Biophys (2016) 0.77

Self-Assembly of Three-Dimensional Nanoporous Containers. Nano (2009) 0.76

Critical assessment of implantable drug delivery devices in glaucoma management. J Drug Deliv (2013) 0.76

Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics. ACS Nano (2017) 0.76

A microfluidic reciprocating intracochlear drug delivery system with reservoir and active dose control. Lab Chip (2014) 0.76

The Smart Drug Delivery System and Its Clinical Potential. Theranostics (2016) 0.76

Visible light and near-infrared-responsive chromophores for drug delivery-on-demand applications. Drug Deliv Transl Res (2015) 0.76

Biomedical microelectromechanical systems (BioMEMS): Revolution in drug delivery and analytical techniques. Saudi Pharm J (2013) 0.76

Biomaterials approaches to combating oral biofilms and dental disease. BMC Oral Health (2006) 0.76

Training an asymmetric signal perceptron through reinforcement in an artificial chemistry. J R Soc Interface (2014) 0.76

DNA nanomaterials for preclinical imaging and drug delivery. J Control Release (2016) 0.75

Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80

Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov (2009) 12.46

Engineering vascularized skeletal muscle tissue. Nat Biotechnol (2005) 7.73

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90

Impact of nanotechnology on drug delivery. ACS Nano (2009) 6.87

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol (2008) 6.81

Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med (2012) 5.92

Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol (2004) 5.51

Transdermal drug delivery. Nat Biotechnol (2008) 5.11

Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A (2002) 4.77

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci U S A (2008) 4.57

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res (2004) 4.56

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol (2005) 4.55

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 4.46

A tough biodegradable elastomer. Nat Biotechnol (2002) 4.35

Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A (2010) 4.25

Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09

Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med (2005) 4.04

Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater (2008) 4.00

A reversibly switching surface. Science (2003) 3.97

Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95

Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A (2008) 3.80

Nanoparticle delivery of cancer drugs. Annu Rev Med (2011) 3.75

Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 3.66

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A (2008) 3.62

First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med (2012) 3.56

Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules (2005) 3.44

Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov (2004) 3.41

Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci (2006) 3.35

Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35

Treating metastatic cancer with nanotechnology. Nat Rev Cancer (2011) 3.30

Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.19

Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med (2008) 3.16

Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol (2010) 3.15

Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater (2010) 3.11

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol (2012) 3.09

Engineering substrate topography at the micro- and nanoscale to control cell function. Angew Chem Int Ed Engl (2009) 3.09

Microengineered hydrogels for tissue engineering. Biomaterials (2007) 2.87

Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci U S A (2003) 2.86

Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl (2003) 2.83

The inflammatory responses to silk films in vitro and in vivo. Biomaterials (2005) 2.79

Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science (2002) 2.79

Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano (2008) 2.76

Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev (2006) 2.69

Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater (2003) 2.65

A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res (2008) 2.63

A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc Natl Acad Sci U S A (2008) 2.58

Macroporous nanowire nanoelectronic scaffolds for synthetic tissues. Nat Mater (2012) 2.57

Light-induced shape-memory polymers. Nature (2005) 2.52

Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation (2005) 2.49

Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42

Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett (2007) 2.40

A vector-free microfluidic platform for intracellular delivery. Proc Natl Acad Sci U S A (2013) 2.40

Development of lipidoid-siRNA formulations for systemic delivery to the liver. Mol Ther (2009) 2.39

An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl (2006) 2.38

Bio-inspired polymer composite actuator and generator driven by water gradients. Science (2013) 2.38

Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett (2010) 2.35

Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip (2007) 2.30

Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials (2003) 2.27

Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng (2004) 2.26

Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng (2005) 2.23

Silk implants for the healing of critical size bone defects. Bone (2005) 2.22

PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21

Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A (2010) 2.21

Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng (2006) 2.20

Micromolding of shape-controlled, harvestable cell-laden hydrogels. Biomaterials (2006) 2.12

Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed (2007) 2.12

Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res (2007) 2.12

Progress in tissue engineering. Sci Am (2009) 2.08

In vivo engineering of organs: the bone bioreactor. Proc Natl Acad Sci U S A (2005) 2.04

Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater (2004) 2.03

Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A (2004) 2.03

Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng (2006) 2.01

In vivo degradation characteristics of poly(glycerol sebacate). J Biomed Mater Res A (2003) 2.01

Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat Biotechnol (2013) 1.97

Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A (2004) 1.94

Measurement and predictors of resilience among community-dwelling older women. J Psychiatr Res (2008) 1.91

Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays. Lab Chip (2005) 1.89

Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Mol Ther (2005) 1.87

Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery. Bioconjug Chem (2003) 1.87

Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett (2009) 1.86

Quantitative and comparative studies of the vocal fold extracellular matrix II: collagen. Ann Otol Rhinol Laryngol (2006) 1.85

A simple soft lithographic route to fabrication of poly(ethylene glycol) microstructures for protein and cell patterning. Biomaterials (2004) 1.84

Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci U S A (2009) 1.83

New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell (2008) 1.82

Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. J Am Chem Soc (2003) 1.81

Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett (2008) 1.80

A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci U S A (2004) 1.79

Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates. Biomaterials (2006) 1.79

Biomaterial microarrays: rapid, microscale screening of polymer-cell interaction. Biomaterials (2005) 1.78

Fabrication and biocompatibility of polypyrrole implants suitable for neural prosthetics. Biomaterials (2005) 1.78

High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng (2003) 1.77

A magnetically triggered composite membrane for on-demand drug delivery. Nano Lett (2009) 1.77

Nanowired three-dimensional cardiac patches. Nat Nanotechnol (2011) 1.76

Fabrication of gradient hydrogels using a microfluidics/photopolymerization process. Langmuir (2004) 1.76

Quantitative and comparative studies of the vocal fold extracellular matrix. I: Elastic fibers and hyaluronic acid. Ann Otol Rhinol Laryngol (2006) 1.74

BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition. Proc Natl Acad Sci U S A (2013) 1.72

Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials (2007) 1.72